WO2000030625A3 - Utilisation de derives de phosphonoformate pour traiter des infections - Google Patents

Utilisation de derives de phosphonoformate pour traiter des infections Download PDF

Info

Publication number
WO2000030625A3
WO2000030625A3 PCT/EP1999/008965 EP9908965W WO0030625A3 WO 2000030625 A3 WO2000030625 A3 WO 2000030625A3 EP 9908965 W EP9908965 W EP 9908965W WO 0030625 A3 WO0030625 A3 WO 0030625A3
Authority
WO
WIPO (PCT)
Prior art keywords
acid derivatives
treating infections
phosphonoformic acid
processes
compound
Prior art date
Application number
PCT/EP1999/008965
Other languages
German (de)
English (en)
Other versions
WO2000030625A2 (fr
Inventor
Hassan Jomaa
Original Assignee
Hassan Jomaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BR9915639-3A priority Critical patent/BR9915639A/pt
Priority to PL99348721A priority patent/PL348721A1/xx
Priority to IL14277699A priority patent/IL142776A0/xx
Priority to AU15556/00A priority patent/AU1555600A/en
Priority to EA200100586A priority patent/EA200100586A1/ru
Priority to JP2000583508A priority patent/JP2002530326A/ja
Application filed by Hassan Jomaa filed Critical Hassan Jomaa
Priority to EP99958099A priority patent/EP1131075A2/fr
Priority to APAP/P/2001/002165A priority patent/AP2001002165A0/en
Priority to CA002352549A priority patent/CA2352549A1/fr
Publication of WO2000030625A2 publication Critical patent/WO2000030625A2/fr
Publication of WO2000030625A3 publication Critical patent/WO2000030625A3/fr
Priority to NO20012541A priority patent/NO20012541L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

L'invention concerne l'utilisation d'un composé de la formule (I) pour assurer la prophylaxie et le traitement de processus infectieux chez l'homme et chez l'animal, induits par des bactéries, des moisissures ou des parasites. Ce composé s'utilise également comme fongicide, bactéricide ou herbicide dans le domaine végétal.
PCT/EP1999/008965 1998-11-25 1999-11-20 Utilisation de derives de phosphonoformate pour traiter des infections WO2000030625A2 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
PL99348721A PL348721A1 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
IL14277699A IL142776A0 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
AU15556/00A AU1555600A (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
EA200100586A EA200100586A1 (ru) 1998-11-25 1999-11-20 Применение производных фосфономуравьиной кислоты для лечения инфекций
JP2000583508A JP2002530326A (ja) 1998-11-25 1999-11-20 感染症の治療のためのホスホノ蟻酸誘導体の使用
BR9915639-3A BR9915639A (pt) 1998-11-25 1999-11-20 Uso de derivados de ácido fosfonofórmico para o tratamento de infecções
EP99958099A EP1131075A2 (fr) 1998-11-25 1999-11-20 Utilisation de derives de phosphonoformate pour traiter des infections
APAP/P/2001/002165A AP2001002165A0 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
CA002352549A CA2352549A1 (fr) 1998-11-25 1999-11-20 Utilisation de derives de phosphonoformate pour traiter des infections
NO20012541A NO20012541L (no) 1998-11-25 2001-05-23 Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854402A DE19854402A1 (de) 1998-11-25 1998-11-25 Verwendung von Phosphonameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen
DE19854402.2 1998-11-25

Publications (2)

Publication Number Publication Date
WO2000030625A2 WO2000030625A2 (fr) 2000-06-02
WO2000030625A3 true WO2000030625A3 (fr) 2000-10-05

Family

ID=7888997

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/008965 WO2000030625A2 (fr) 1998-11-25 1999-11-20 Utilisation de derives de phosphonoformate pour traiter des infections

Country Status (16)

Country Link
EP (1) EP1131075A2 (fr)
JP (1) JP2002530326A (fr)
CN (1) CN1328465A (fr)
AP (1) AP2001002165A0 (fr)
AU (1) AU1555600A (fr)
BR (1) BR9915639A (fr)
CA (1) CA2352549A1 (fr)
CZ (1) CZ20011821A3 (fr)
DE (1) DE19854402A1 (fr)
EA (1) EA200100586A1 (fr)
IL (1) IL142776A0 (fr)
NO (1) NO20012541L (fr)
OA (1) OA11717A (fr)
PL (1) PL348721A1 (fr)
TR (1) TR200101433T2 (fr)
WO (1) WO2000030625A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004080443A1 (fr) * 2003-03-14 2004-09-23 Epistem Limited Traitement et/ou prevention d'une deterioration epitheliale non virale
US20050171063A1 (en) * 2003-10-20 2005-08-04 Pawan Malhotra Use of phosphono derivatives as anti-malarials
US9808011B2 (en) 2014-12-15 2017-11-07 Biovectra Inc. Pentacyclic triterpene compounds and uses thereof
CN105794493A (zh) * 2016-03-11 2016-07-27 钦州市凤源泉生物科技有限公司 一种提高红椎菌主要活性成分的培养方法
KR101797926B1 (ko) * 2016-11-21 2017-11-15 한국식품연구원 포름산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
KR101912774B1 (ko) * 2016-11-21 2018-10-29 한국식품연구원 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
CN108948005A (zh) * 2018-07-03 2018-12-07 湖南华腾制药有限公司 聚乙二醇修饰的依诺沙星及应用
KR102641583B1 (ko) * 2018-10-23 2024-02-28 건국대학교 산학협력단 지도부딘을 포함하는 식물병 방제용 조성물
CN114983999A (zh) * 2022-06-09 2022-09-02 四川大学 一种青蒿素及其衍生物的新用途、验证方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016537A1 (fr) * 1996-10-11 1998-04-23 Astra Aktiebolag (Publ) Nouveaux composes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016537A1 (fr) * 1996-10-11 1998-04-23 Astra Aktiebolag (Publ) Nouveaux composes

Also Published As

Publication number Publication date
TR200101433T2 (tr) 2001-10-22
CA2352549A1 (fr) 2000-06-02
NO20012541D0 (no) 2001-05-23
CZ20011821A3 (cs) 2001-09-12
PL348721A1 (en) 2002-06-03
EA200100586A1 (ru) 2001-12-24
AP2001002165A0 (en) 2001-06-30
NO20012541L (no) 2001-07-24
BR9915639A (pt) 2001-08-07
IL142776A0 (en) 2002-03-10
CN1328465A (zh) 2001-12-26
DE19854402A1 (de) 2000-05-31
EP1131075A2 (fr) 2001-09-12
WO2000030625A2 (fr) 2000-06-02
JP2002530326A (ja) 2002-09-17
OA11717A (en) 2005-01-26
AU1555600A (en) 2000-06-13

Similar Documents

Publication Publication Date Title
WO1999052515A3 (fr) Utilisation de liaisons organophosphorees dans le traitement et la prevention d'infections
AR087990A2 (es) Combinaciones de compuestos activos, metodo para controlar composiciones fungicidas e insecticidas, uso de esas combinaciones o composiciones para controlar hongos e insectos, y procedimiento para la preparacion de esas composiciones
WO2001028339A3 (fr) Composition antimicrobienne comprenant un acide organique biologiquement actif
DK0514768T3 (fr)
GR3022353T3 (en) Biguanide derivatives, manufacturing method thereof, and disinfectants containing the derivatives
YU2201A (sh) Fosfororganska jedinjenja i njihova upotreba
MXPA04000874A (es) Composicion funguicida y uso de la composicion para controlar las enfermedades de las plantas.
WO2000030625A3 (fr) Utilisation de derives de phosphonoformate pour traiter des infections
WO2000044359A3 (fr) Utilisation de derives thiadiazoliques pour le traitement prophylactique et therapeutique d'infections
GT200200146A (es) Nuevos compuestos fungicidas
MY131067A (en) Selective herbicides comprising a tetrazolinone derivative
MXPA04004557A (es) Composicion fungicida basada en derivado de piridilmetilbenzamida y derivado de valinamida.
WO2000066094A3 (fr) Utilisation de composes comportant un heterocycle azote-oxygene
AP2001002106A0 (en) Use of organophosphorus compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide.
IS5956A (is) Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla
WO2000030653A3 (fr) Utilisation de derives de phosphonoformate pour traiter des infections
WO2000044358A3 (fr) Utilisation de composes organophosphores pour la prophylaxie et le traitement des infections
WO2003017766A3 (fr) Herbicides a base de cetones d'aryle substituees
WO1999063827A8 (fr) Agents permettant de lutter contre les dommages causes par des maladies bacteriennes dans les domaines de l'agriculture et de l'horticulture
ATE146458T1 (de) Insektizid- und akarizid-diphenyl-carbonitrile sowie diarylnitropyrrolderivate
NO20013464L (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
WO2001092341A8 (fr) Compose de glucal, son procede de preparation et ses applications
WO2001049668A3 (fr) 4-aryl-1-difluoromethoxyimidazole
BRPI0415077A (pt) misturas fungicidas para combater patógenos de arroz, agente fungicida, processo para combater fungos nocivos, semente, e, uso de compostos

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99813703.0

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2000 15556

Country of ref document: AU

Kind code of ref document: A

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 142776

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: IN/PCT/2001/00510/MU

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 15556/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: PV2001-1821

Country of ref document: CZ

Ref document number: 2001/01433

Country of ref document: TR

ENP Entry into the national phase

Ref document number: 2352549

Country of ref document: CA

Ref document number: 2352549

Country of ref document: CA

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2000 583508

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 09856804

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: AP/P/2001/002165

Country of ref document: AP

WWE Wipo information: entry into national phase

Ref document number: 1999958099

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 200100586

Country of ref document: EA

WWP Wipo information: published in national office

Ref document number: 1999958099

Country of ref document: EP

Ref document number: PV2001-1821

Country of ref document: CZ

WWR Wipo information: refused in national office

Ref document number: PV2001-1821

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1999958099

Country of ref document: EP